Work

Clinical outcomes of metastatic urothelial carcinoma pts discontinuing enfortumab vedotin.

Year: 2025

Type: conference-abstract

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e16574

Authors: Jasmeet Kaur, Nagendra Dhanikonda, Karthik Devarajan, Fern Anari, Matthew R. Zibelman, Daniel M. Geynisman, Elizabeth R. Plimack, Pooja Ghatalia

Institutions: Fox Chase Cancer Center, Temple University Hospital

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410815602

Cites:

Cited by:

Related to: 10